New Advances in the Study of Bone Tumors: A Lesson From the 3D Environment.

3D culture bone metastasis microenvironment sarcoma tumor niche

Journal

Frontiers in physiology
ISSN: 1664-042X
Titre abrégé: Front Physiol
Pays: Switzerland
ID NLM: 101549006

Informations de publication

Date de publication:
2019
Historique:
received: 08 04 2019
accepted: 11 06 2019
entrez: 19 7 2019
pubmed: 19 7 2019
medline: 19 7 2019
Statut: epublish

Résumé

Bone primary tumors, such as osteosarcoma, are highly aggressive pediatric tumors that in 30% of the cases develop lung metastasis and are characterized by poor prognosis. Bone is also the third most common metastatic site in patients with advanced cancer and once tumor cells become homed to the skeleton, the disease is usually considered incurable, and treatment is only palliative. Bone sarcoma and bone metastasis share the same tissue microenvironment and niches. 3D cultures represent a new promising approach for the study of interactions between tumor cells and other cellular or acellular components of the tumor microenvironment (i.e., fibroblasts, mesenchymal stem cells, bone ECM). Indeed, 3D models can mimic physiological interactions that are crucial to modulate response to soluble paracrine factors, tumor drug resistance and aggressiveness and, in all, these innovative models might be able of bypassing the use of animal-based preclinical cancer models. To date, both static and dynamic 3D cell culture models have been shown to be particularly suited for screening of anticancer agents and might provide accurate information, translating

Identifiants

pubmed: 31316395
doi: 10.3389/fphys.2019.00814
pmc: PMC6611422
doi:

Types de publication

Journal Article

Langues

eng

Pagination

814

Références

Biotechnol Bioeng. 2003 Jul 20;83(2):173-80
pubmed: 12768623
Biomaterials. 2005 Mar;26(9):979-86
pubmed: 15369686
Int J Cancer. 2006 Aug 15;119(4):839-46
pubmed: 16557578
Cell. 2006 Aug 25;126(4):677-89
pubmed: 16923388
Lab Chip. 2007 Mar;7(3):302-9
pubmed: 17330160
FASEB J. 2007 Nov;21(13):3763-70
pubmed: 17586727
Int J Cancer. 2008 Aug 15;123(4):831-7
pubmed: 18537159
Clin Orthop Relat Res. 2008 Sep;466(9):2081-91
pubmed: 18543051
Int J Cancer. 2009 Jan 15;124(2):326-32
pubmed: 19003962
J Bone Joint Surg Am. 2009 Jun;91(6):1546-56
pubmed: 19487537
J Pathol. 2009 Nov;219(3):294-305
pubmed: 19718709
Lab Chip. 2010 Apr 21;10(8):939-56
pubmed: 20358102
Acta Biomater. 2010 Nov;6(11):4305-13
pubmed: 20570642
Methods Mol Biol. 2011;695:17-39
pubmed: 21042963
J Cell Biochem. 2011 Dec;112(12):3704-13
pubmed: 21815187
Trends Cell Biol. 2011 Dec;21(12):745-54
pubmed: 22033488
Proc Natl Acad Sci U S A. 2012 Aug 21;109(34):13515-20
pubmed: 22869695
Exp Cell Res. 2013 Jan 1;319(1):75-87
pubmed: 23022396
J Cell Physiol. 2013 Apr;228(4):846-52
pubmed: 23042366
Drug Discov Today. 2013 Mar;18(5-6):240-9
pubmed: 23073387
Expert Opin Drug Deliv. 2013 Mar;10(3):369-83
pubmed: 23289593
Front Oncol. 2013 Mar 05;3:44
pubmed: 23467856
Proc Natl Acad Sci U S A. 2013 Apr 16;110(16):6500-5
pubmed: 23576741
Proteomics. 2013 Aug;13(15):2351-60
pubmed: 23712969
Clin Sarcoma Res. 2013 Jul 23;3(1):10
pubmed: 23880362
Lab Invest. 2013 Oct;93(10):1100-14
pubmed: 23958880
Am J Physiol Cell Physiol. 2014 Jan 15;306(2):C80-8
pubmed: 24133063
Ann Biomed Eng. 2014 Feb;42(2):352-67
pubmed: 24297495
Biomaterials. 2014 Mar;35(8):2454-61
pubmed: 24388382
Curr Pathobiol Rep. 2014 Mar 1;2(1):41-52
pubmed: 24660130
Nat Methods. 2014 Jun;11(6):663-9
pubmed: 24793454
Adv Drug Deliv Rev. 2014 Dec 15;79-80:155-71
pubmed: 25109853
Lab Chip. 2015 Mar 21;15(6):1481-7
pubmed: 25608968
Biochim Biophys Acta. 2015 Oct;1848(10 Pt B):2677-84
pubmed: 25687976
J Adv Res. 2015 Mar;6(2):105-21
pubmed: 25750745
Int J Cancer. 2015 Oct 15;137(8):1842-54
pubmed: 25868708
Cell Mol Life Sci. 2015 Aug;72(16):3097-113
pubmed: 25935149
Curr Opin Biotechnol. 2015 Dec;35:118-26
pubmed: 26094109
J Control Release. 2015 Oct 10;215:39-54
pubmed: 26220617
Mol Neurobiol. 2016 Dec;53(10):7184-7199
pubmed: 26687184
J Biotechnol. 2016 Mar 10;221:118-29
pubmed: 26815388
Trends Cancer. 2016 Jan 1;2(1):6-19
pubmed: 26858990
J Thromb Haemost. 2016 Mar;14(3):619-22
pubmed: 26933837
Cell Biol Int. 2016 Jun;40(6):610-8
pubmed: 26992453
Methods Mol Biol. 2016;1502:203-11
pubmed: 27115504
Drug Des Devel Ther. 2016 Jul 04;10:2155-65
pubmed: 27445462
Int J Biochem Cell Biol. 2016 Oct;79:168-180
pubmed: 27590854
J Biol Inorg Chem. 2016 Dec;21(8):1009-1020
pubmed: 27696106
J Bone Oncol. 2016 Jul 21;5(3):112-116
pubmed: 27761369
PLoS One. 2016 Nov 16;11(11):e0166500
pubmed: 27851822
Int J Cancer. 2017 Mar 15;140(6):1331-1345
pubmed: 27888521
Onco Targets Ther. 2016 Nov 22;9:7207-7218
pubmed: 27920558
Tissue Eng Part A. 2017 Jan;23(1-2):80-89
pubmed: 27923328
Cancer Sci. 2017 Mar;108(3):283-289
pubmed: 28064442
Cancer Discov. 2017 May;7(5):462-477
pubmed: 28331002
Adv Healthc Mater. 2017 Aug;6(15):null
pubmed: 28544639
Biofabrication. 2017 Aug 03;9(3):032003
pubmed: 28707624
Int J Mol Sci. 2017 Jul 21;18(7):null
pubmed: 28754000
Cancer Lett. 2017 Oct 1;405:90-99
pubmed: 28774797
Biochim Biophys Acta Mol Basis Dis. 2017 Dec;1863(12):3254-3264
pubmed: 28866133
Exp Cell Res. 2017 Nov 15;360(2):138-145
pubmed: 28867479
Oncotarget. 2017 Apr 13;8(33):54478-54496
pubmed: 28903357
Calcif Tissue Int. 2018 Feb;102(2):227-250
pubmed: 29079995
BMC Cancer. 2017 Nov 2;17(1):709
pubmed: 29096610
Sci Rep. 2017 Nov 10;7(1):15285
pubmed: 29127321
Adv Healthc Mater. 2018 Mar;7(6):e1700980
pubmed: 29205942
Lab Chip. 2018 Jan 16;18(2):304-314
pubmed: 29211088
J Exp Clin Cancer Res. 2018 Jan 5;37(1):2
pubmed: 29304852
Biochim Biophys Acta Rev Cancer. 2018 Apr;1869(2):117-127
pubmed: 29360544
Proc Natl Acad Sci U S A. 2018 Feb 6;115(6):1256-1261
pubmed: 29363599
Small. 2018 Mar;14(12):e1702787
pubmed: 29399951
Int J Mol Sci. 2018 Feb 21;19(2):
pubmed: 29466296
J Orthop Res. 2018 Feb 22;:null
pubmed: 29469166
Sci Adv. 2018 Apr 27;4(4):eaas8998
pubmed: 29719868
J Bone Miner Res. 2018 Dec;33(12):2099-2113
pubmed: 30476357
Nat Rev Cancer. 2019 Feb;19(2):65-81
pubmed: 30647431
Micromachines (Basel). 2019 Feb 27;10(3):null
pubmed: 30818801
Cancer Metastasis Rev. 2019 Jun;38(1-2):133-147
pubmed: 30825056
J Natl Cancer Inst. 1971 Jan;46(1):113-20
pubmed: 5101993
Anticancer Res. 1996 Sep-Oct;16(5A):2773-80
pubmed: 8917385

Auteurs

Margherita Cortini (M)

Orthopaedic Pathophysiology and Regenerative Medicine Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Nicola Baldini (N)

Orthopaedic Pathophysiology and Regenerative Medicine Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.
Department of Biomedical and Neuromotor Sciences, University of Bologna, Bologna, Italy.

Sofia Avnet (S)

Orthopaedic Pathophysiology and Regenerative Medicine Unit, IRCCS Istituto Ortopedico Rizzoli, Bologna, Italy.

Classifications MeSH